Application of risk management for nursing patients with hematologic malignancies

Abstract

Abstract
Background: Minimal data is available for the critical care of the hematological malignant patients. In this study quality of care was compared for the hematological and the solid tumor patients. The malignant patients are more prone to death due to decreased nursing care. They require more careful treatment than any other disease.
Methods: Patients with cancer during September 2019 and February 2021, who had undergone critical care were included in this study. Data was obtained from the hospitals databases.
Results: Out of the 814 patients, only 114 patients were included in this study. 30-day life hematological malignant patients are 55% as compared to other cancer types which amount to 2.8% P value is 0.03, a similar observation has been found in the admission at the hospital (78.9%) as compared to the other patients 46.9% p value less than 0.001, less than 2 days of hospitalization is 24% in the case of the malignant cancers as compared to the other patients (P value less than 0.001). The aggressive care composite score is higher among the malignant patients relatively as compared to other patients. In the multivariate analysis it has been found that malignancy is associated with aggressive life care (P<0.001).
Conclusion: It has been concluded that malignant cancer patients have received more care as compared to other patients at the hospital. [Ethiop. J. Health Dev. 2022; 36(3) 00-00]
Keywords: Palliative care; Intensive care unit; Hematological malignant cancer; solid tumour; Chemotherapy